Clearly demonstrating you have no idea what you are investing in.
Blinatumomab targets CD19, which OnCARlytics is being used in combination with.
Honestly.
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-08528
- Forums
- ASX - By Stock
- Ann: First Australian Patient Dosed in Phase 1b azer-cel Trial
IMU
imugene limited
Add to My Watchlist
8.33%
!
1.1¢

Clearly demonstrating you have no idea what you are investing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $82.13M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.1¢ | $177.1K | 14.74M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
76 | 16845799 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 17837721 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 16767715 | 0.011 |
80 | 23229175 | 0.010 |
24 | 7564263 | 0.009 |
9 | 1739999 | 0.008 |
5 | 1780000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 16837721 | 31 |
0.013 | 13080503 | 32 |
0.014 | 8359185 | 33 |
0.015 | 9008204 | 32 |
0.016 | 7428011 | 30 |
Last trade - 14.45pm 25/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |